Susan D. Spencer

9.6k total citations · 3 hit papers
36 papers, 5.5k citations indexed

About

Susan D. Spencer is a scholar working on Oncology, Electrical and Electronic Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susan D. Spencer has authored 36 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Electrical and Electronic Engineering and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susan D. Spencer's work include HER2/EGFR in Cancer Research (8 papers), Organic Electronics and Photovoltaics (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Susan D. Spencer is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Organic Electronics and Photovoltaics (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Susan D. Spencer collaborates with scholars based in United States, Canada and France. Susan D. Spencer's co-authors include Laurence A. Lasky, Sharon Pitts-Meek, Karen Chen, Merry Nishimura, Craig Crowley, Heidi Phillips, Guangmin Li, Gail D. Lewis Phillips, Donald Dowbenko and Mark X. Sliwkowski and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Susan D. Spencer

34 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

2008 1.3k citations Gail D. Lewis Phillips, Guangmin Li et al. Cancer Research profile →
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand

1994 1.1k citations Susan D. Spencer et al. profile →
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons

1994 874 citations Craig Crowley, Susan D. Spencer et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan D. Spencer United States	24	2.0k	1.7k	1.3k	1.1k	862	36	5.5k
Czeslaw Radziejewski United States	26	6.6k 3.3×	1.9k 1.1×	1.5k 1.1×	369 0.4×	840 1.0×	39	10.5k
Yosef Yarden Israel	27	3.2k 1.6×	1.6k 0.9×	780 0.6×	185 0.2×	575 0.7×	49	4.9k
David T. Shima United Kingdom	45	7.8k 3.9×	1.2k 0.7×	2.0k 1.5×	345 0.3×	785 0.9×	83	12.0k
Jasti S. Rao United States	54	4.4k 2.2×	2.4k 1.4×	225 0.2×	750 0.7×	641 0.7×	169	8.3k
Sara M. Weis United States	31	4.3k 2.2×	1.6k 0.9×	413 0.3×	234 0.2×	932 1.1×	53	7.3k
Reidar Albrechtsen Denmark	44	2.6k 1.3×	1.6k 0.9×	343 0.3×	296 0.3×	586 0.7×	112	6.0k
Irit Lax United States	51	8.5k 4.3×	2.8k 1.6×	1.8k 1.4×	342 0.3×	1.2k 1.4×	80	11.6k
Julie L. Prior United States	33	1.8k 0.9×	1.5k 0.9×	309 0.2×	702 0.7×	1.0k 1.2×	63	4.1k
Paola Defilippi Italy	41	3.8k 1.9×	1.3k 0.7×	316 0.2×	366 0.3×	1.0k 1.2×	106	6.8k
Ola Söderberg Sweden	39	5.2k 2.6×	1.2k 0.7×	579 0.4×	178 0.2×	1.2k 1.4×	97	7.7k

Countries citing papers authored by Susan D. Spencer

Since Specialization

Citations

This map shows the geographic impact of Susan D. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan D. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan D. Spencer more than expected).

Fields of papers citing papers by Susan D. Spencer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan D. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan D. Spencer. The network helps show where Susan D. Spencer may publish in the future.

Co-authorship network of co-authors of Susan D. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Susan D. Spencer. A scholar is included among the top collaborators of Susan D. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan D. Spencer. Susan D. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gregson, Stephen J., Luke A. Masterson, BinQing Wei, et al.. (2017). Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers. Journal of Medicinal Chemistry. 60(23). 9490–9507. 27 indexed citations

Asundi, Jyoti, Lisa Crocker, Jarrod R. Tremayne, et al.. (2015). An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies. Clinical Cancer Research. 21(14). 3252–3262. 28 indexed citations

Yu, Shang‐Fan, Bing Zheng, MaryAnn Go, et al.. (2015). A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs. Clinical Cancer Research. 21(14). 3298–3306. 125 indexed citations

Verma, Vishal, Thomas H. Pillow, Guangmin Li, et al.. (2015). The cryptophycins as potent payloads for antibody drug conjugates. Bioorganic & Medicinal Chemistry Letters. 25(4). 864–868. 51 indexed citations

Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models. Molecular Cancer Therapeutics. 13(11). 2630–2640. 52 indexed citations

Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). Abstract 4494: A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers. Cancer Research. 74(19_Supplement). 4494–4494. 1 indexed citations

Kelley, Kyle P., et al.. (2013). Nanoscale Thermal Analysis of Organic Solar Cells. Bulletin of the American Physical Society. 2013.

Spencer, Susan D., et al.. (2013). Characterization of organic solar cell morphology. Bulletin of the American Physical Society. 2013.

Polson, Andrew G., Bing Zheng, MaryAnn Go, et al.. (2013). Abstract 4634: Anthracycline based antibody-drug conjugates (ADCs) for the treatment of non-Hodgkin's lymphoma are effective in cell lines resistant to auristatin based ADCs.. Cancer Research. 73(8_Supplement). 4634–4634. 1 indexed citations

10.

Junutula, Jagath R., Kelly M. Flagella, Richard Graham, et al.. (2010). Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Clinical Cancer Research. 16(19). 4769–4778. 214 indexed citations

11.

Collison, Christopher J., et al.. (2010). A New Model for Quantifying the Extent of Interaction between Soluble Polyphenylene-Vinylenes and Single-Walled Carbon Nanotubes in Solvent Dispersions. The Journal of Physical Chemistry B. 114(34). 11002–11009. 11 indexed citations

12.

Phillips, Gail D. Lewis, Guangmin Li, Debra L. Dugger, et al.. (2008). Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate. Cancer Research. 68(22). 9280–9290. 1259 indexed citations breakdown →

13.

Côté, Jean‐François, Jean-François Théberge, Maxime Hallé, et al.. (2002). PSTPIP Is a Substrate of PTP-PEST and Serves as a Scaffold Guiding PTP-PEST Toward a Specific Dephosphorylation of WASP. Journal of Biological Chemistry. 277(4). 2973–2986. 98 indexed citations

14.

Ross, Sarajane, Susan D. Spencer, Laurence A. Lasky, & Hartmut Koeppen. (2001). Selective Expression of Murine Prostate Stem Cell Antigen in Fetal and Adult Tissues and the Transgenic Adenocarcinoma of the Mouse Prostate Model of Prostate Carcinogenesis. American Journal Of Pathology. 158(3). 809–816. 21 indexed citations

15.

Wu, Yan, Donald Dowbenko, Susan D. Spencer, et al.. (2000). Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase. Journal of Biological Chemistry. 275(28). 21477–21485. 223 indexed citations

16.

Cong, Feng, Susan D. Spencer, Jean‐François Côté, et al.. (2000). Cytoskeletal Protein PSTPIP1 Directs the PEST-Type Protein Tyrosine Phosphatase to the c-Abl Kinase to Mediate Abl Dephosphorylation. Molecular Cell. 6(6). 1413–1423. 93 indexed citations

17.

Dowbenko, Donald, Susan D. Spencer, Clifford Quan, & Laurence A. Lasky. (1998). Identification of a Novel Polyproline Recognition Site in the Cytoskeletal Associated Protein, Proline Serine Threonine Phosphatase Interacting Protein. Journal of Biological Chemistry. 273(2). 989–996. 27 indexed citations

18.

Wu, Yan, Susan D. Spencer, & Laurence A. Lasky. (1998). Tyrosine Phosphorylation Regulates the SH3-mediated Binding of the Wiskott-Aldrich Syndrome Protein to PSTPIP, a Cytoskeletal-associated Protein. Journal of Biological Chemistry. 273(10). 5765–5770. 116 indexed citations

19.

Chen, Karen, et al.. (1997). Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits. Journal of Neuroscience. 17(19). 7288–7296. 175 indexed citations

20.

Crowley, Craig, Susan D. Spencer, Merry Nishimura, et al.. (1994). Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 76(6). 1001–1011. 874 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact